Feasibility of using maternal cancer screening visits to identify adolescent girls eligible for human papillomavirus vaccination.
OBJECTIVE
Breast or cervical cancer screening visits may present an opportunity to motivate mothers to have their daughters vaccinated against human papillomavirus (HPV). In preparation for a future intervention study, we sought to establish the feasibility of using these visits to identify women with at least one daughter in the appropriate age range for adolescent HPV vaccination.


METHODS
We conducted a cross-sectional mailed survey of women who had received breast or cervical cancer screening within the 6-18 months before the survey. The study was conducted at two diverse institutions: one serving a mostly black (54.1%) urban inner-city population and another serving a mostly white (87.5%) suburban population.


RESULTS
Our overall response rate was 28% (n = 556) in the urban site and 38% (n = 381) in the suburban site. In the urban site, the proportions of mothers completing mammography or Pap smear visits with HPV vaccine-eligible daughters were 23% and 24%, respectively. In the suburban site, the proportions of mothers completing mammography or Pap smear with at least one vaccine-eligible daughter were 41% and 26%, respectively.


CONCLUSIONS
Women who undergo breast or cervical cancer screening in the two different demographic groups evaluated have at least one adolescent daughter at the appropriate age for HPV vaccination. An important implication of this finding in adolescent daughters of urban mothers is the potential use of maternal breast or cervical cancer screening encounters to target a potentially undervaccinated group.
Department of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0030, USA. rcarlos@umich.edu
Ruth C
RC
Carlos
Amanda F
AF
Dempsey
Ken
K
Resnicow
Mack T
MT
Ruffin
Divya A
DA
Patel
Christopher M
CM
Straus
Andrew
A
Kure
Vanessa K
VK
Dalton
D000293:Adolescent; D000328:Adult; D044383:Black People / Q000523:psychology / Q000706:statistics & numerical data; D001943:Breast Neoplasms / Q000175:diagnosis*; D003430:Cross-Sectional Studies; D005240:Feasibility Studies; D005260:Female; D006306:Health Surveys; D006801:Humans; D008327:Mammography; D008824:Michigan; D008875:Middle Aged; D009679:Nuclear Family; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D010298:Parity; D011247:Pregnancy; D013383:Suburban Population / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D014505:Urban Population / Q000706:statistics & numerical data; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*; D044465:White People / Q000523:psychology / Q000706:statistics & numerical data; D001741:Black or African American
D053918:Papillomavirus Vaccines